Vycor Medical (VYCO) Payables (2010 - 2026)

Vycor Medical (VYCO) has reported Payables for 17 consecutive years, with $3.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 10.31% year-over-year to $3.5 million in Q2 2026; TTM through Jun 2026 was $3.5 million, a 10.31% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 8.62% from the prior year.
• Payables was $3.5 million for Q2 2026 at Vycor Medical, roughly flat from $3.5 million in the prior quarter.
• Over five years, Payables peaked at $3.5 million in Q2 2026 and troughed at $426773.0 in Q2 2023.
• A 5-year average of $2.1 million and a median of $2.9 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables tumbled 30.37% in 2023 and surged 581.33% in 2024, its largest moves.
• Over 5 years, Payables stood at $524755.0 in 2022, then jumped by 417.7% to $2.7 million in 2023, then increased by 12.89% to $3.1 million in 2024, then gained by 8.62% to $3.3 million in 2025, then rose by 4.98% to $3.5 million in 2026.
• The last three Payables figures came in at $3.5 million (Q2 2026), $3.5 million (Q1 2026), and $3.3 million (Q4 2025), per Business Quant data.